Key points from article :
Paradromics, a brain-computer interface company, will test its brain implant on humans in 2025.
Their implant focuses on collecting data from a large number of neurons.
This technology is aimed at helping patients who have lost their ability to communicate.
The implant is wireless and requires a calibration routine to learn the user's intentions.
Their initial focus is on treating severe medical conditions.
“Paradromics’ mission is to transform otherwise untreatable health conditions in brain health into solvable technology problems,” - Matt Angle, CEO and founder of Paradromics.
Anticipates commercial approval by 2029 at the earliest, and the device will retail for about $100,000 each.
